BeiGene Ltd.

(BGNE) Trade

By |

Profile

BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent.

Contact Information

Website: www.beigene.com
Email: ir@beigene.com
Main Phone: +1 345 949-4123
Address: c/o Mourant Ozannes Corporate Services (Cayman) Limited
Address 2: 94 Solaris Avenue, Camana Bay
City / Town: Grand Cayman
Country: CYM
Postal Code: KY1-1108

Issuer Information

Exchange: NGS
CEO: John V. Oyler
Employees: 1300
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 163.50 $ 2.75 (1.71%)
Last Price 163.50 Change $ 2.75 Change % 1.71 Tick N/A
Bid 160.00 Bid Size 100.00 Ask 165.00 Ask Size 100.00
Open 161.72 High 164.64 Low 161.72 Prev Close 160.75
Last Trade Volume 138,412 52 Wk Hi 220.10 52 Wk Low 77.54
Market Cap 9.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 59,212,552.00 EPS (TTM) -4.68 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 225 225 225 225
Low Target Price Estimate 197 197 172 200
Mean Target Price Estimate 207.25 207.25 201 211
Standard Deviation 12.55 12.55 22.02 10.55
Date of Most Recent Estimate 05/24/18 05/24/18 05/17/18 06/18/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 3
Moderate Buy 1 1 1 1
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.1 1.42 1.42 1.5